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ucleotide oligomerization domain (NOD) 2
functions as a mammalian cytosolic pathogen
recognition molecule, and mutant forms have
been genetically linked to Crohn’s disease (CD). NOD2
associates with the caspase activation and recruitment
domain of RIP-like interacting caspase-like apoptosis
regulatory protein kinase (RICK)/RIP2 and activates nu-
clear factor (NF)–
 
 
 
B in epithelial cells and macrophages,
whereas NOD2 mutant 3020insC, which is associated
with CD, shows an impaired ability to activate NF-
 
 
 
B. To
gain insight into the molecular mechanisms of NOD2
N
 
function, we performed a functional analysis of deletion
and substitution NOD2 mutants. NOD2, but not NOD2
3020insC mutant, associated with cell surface mem-
branes of intestinal epithelial cells. Membrane targeting
and subsequent NF-
 
 
 
B activation are mediated by two
leucine residues and a tryptophan-containing motif in
the COOH-terminal domain of NOD2. The membrane
targeting of NOD2 is required for NF-
 
 
 
B activation after
the recognition of bacterial muramyl dipeptide in intesti-
nal epithelial cells.
 
Introduction
 
Nucleotide oligomerization domain (NOD) 2/caspase activa-
tion and recruitment domain
 
 
 
(CARD) 15 was the first gene
linked to the risk of Crohn’s disease (CD; Hugot et al., 2001;
Ogura et al., 2001a). NOD2 expression has been found in intes-
tinal epithelial cells (Ogura et al., 2001b; Gutierrez et al., 2002;
Hisamatsu et al., 2003), including Paneth cells (Berrebi et al.,
2003; Rosenstiel et al., 2003) and monocytes. NOD2 recog-
nizes and reacts to the bacterial component muramyl dipeptide
L-Ala, D-Glx (MDP-LD) via its COOH-terminal leucine-rich
repeat domain (Girardin et al., 2003; Inohara et al., 2003). In
contrast, the 3020insC mutant form of NOD2, which is associ-
ated with CD, does not respond to MDP stimulation (Bonen et
al., 2003; Chamaillard et al., 2003; Girardin et al., 2003; Ino-
hara et al., 2003). NOD2 activates the nuclear translocation of
the transcription nuclear factor (NF)–
 
 
 
B, and RICK (RIP-like
interacting caspase-like apoptosis regulatory protein kinase)/
RIP2 is essential for this process (Chin et al., 2002; Kobayashi
et al., 2002). After the activation of NOD proteins, RICK inter-
acts through homophilic CARD–CARD interaction and leads
to the nuclear translocation of NF-
 
 
 
B (Bertin et al., 1999; Ino-
hara et al., 1999; Ogura et al., 2001b; Kobayashi et al., 2002).
RICK/RIP2 is involved in the NOD2-dependent activation of
NF-
 
 
 
B, and NOD2 activation leads to the ubiquitinylation of
the NF-
 
 
 
B essential modulator (NEMO), which is a key compo-
nent of the NF-
 
 
 
B signaling complex (Abbott et al., 2004). Re-
cent studies do not clearly conclude whether NOD2 is a regula-
tor of TLR2-mediated responses that may be deregulated in the
presence of the NOD2 3020insC mutant (Watanabe et al.,
2004; Kobayashi et al., 2005; Maeda et al., 2005). Direct inter-
action between NOD2 and TGF-
 
 
 
–activated kinase 1 and
NOD2 and GRIM-19 have also been shown, and each can
regulate NOD2-mediated NF-
 
 
 
B activation (Chen et al.,
2004; Barnich et al., 2005).
The subcellular localization and trafficking of NOD2/
CARD15 during MDP stimulation, which is the minimal bioac-
tive component of the bacterial peptidoglycan, remain unclear.
A recent study described regulatory regions and characterized
critical residues of NOD2 that are involved in NF-
 
 
 
B activation
after MDP stimulation (Tanabe et al., 2004). Several mutations
of NOD2 leading to the loss of MDP recognition involve amino
acid residues that are predicted to be located in the 
 
 
 
-helix/
turn regions that form the convex face of the leucine-rich repeat.
 
Correspondence to Daniel K. Podolsky: dpodolsky@partners.org
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domain; CD, Crohn’s disease; MDP, muramyl dipeptide; NOD2, nucleotide oli-
gomerization domain 2; NF, nuclear factor; RICK, RIP-like interacting caspase-
like apoptosis regulatory protein kinase. 
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In this study, we demonstrate that NOD2 can be directed to the
intracellular vesicle compartment and cell surface membranes in
intestinal epithelial cells. In these cells, the membrane association
of NOD2 is necessary for NF-
 
 
 
B activation after MDP stimula-
tion. The ability of NOD2 to function as a bacterial recognition
molecule depends on the COOH-terminal protein motif.
 
Results and discussion
 
Cellular localization of endogenous NOD2/
CARD15 in intestinal epithelial cells
 
Expression of NOD2/CARD15 was assessed by Western blot
analysis in several intestinal epithelial cell lines as well as in
COS7 and HEK293 cells. Colo205, SW480, HT29, and LS174
exhibited a strong expression of endogenous NOD2. In contrast,
T84 and Caco-2 expressed little or no NOD2 protein. No endog-
enous expression was observed in COS7 or HEK293 cells (Fig.
1 A). NOD2 that was expressed in HT29 did not contain any of
the three common mutations that are associated with CD, and
stimulation by MDP-LD induced a 6.2-fold increase in NF-
 
 
 
B
activity, indicating functional NOD2 in this cell line (Fig. 1 B).
Immunostaining of HT29 cells with a rabbit NOD2 anti-
serum revealed cytoplasmic and vesicular staining and mem-
brane association. No membrane staining was observed with
preimmune serum. In addition, no staining was observed in
Caco-2 cells lacking endogenous NOD2 (Fig. 1 C). In colonic
epithelial cells, MDP-LD may be taken up by the hPepT1
transporter (Vavricka et al., 2004). The expression of this trans-
porter is increased in chronically inflamed intestinal mucosa. If
MDP-LD is indeed taken up via the hPepT1 transporter, the
membrane targeting of NOD2 could play a crucial role in the
activation of NF-
 
 
 
B, allowing MDP to interact with NOD2.
 
The COOH-terminal domain of NOD2 
facilitates membrane targeting
 
Given the fact that the NOD2 3020insC mutant, which is associ-
ated with CD, did not respond to MDP-LD stimulation, the
membrane association that was observed for NOD2 led us to ex-
amine the subcellular localization of the NOD2 3020insC mu-
tant. Confocal microscopic examination of Caco-2 and COS7
cells that were transfected with Flag or GFP-tagged NOD2 was
performed to achieve finer delineation of the spatial distribution
of NOD2. Confocal analysis showed that the expressed protein
Flag-NOD2 is located in the cytosol and also appears enriched
close to the plasma membrane, recapitulating the distribution of
endogenous NOD2 (Fig. 2 B). In contrast to wild-type NOD2,
Flag-NOD2 3020insC mutant was only present in the cytosol
and vesicular compartment. The loss of membrane targeting of
the NOD2 3020insC mutant was confirmed by Western blot
analysis after separation of cytosolic and membrane fractions.
The relative purity of cytosolic and membrane fractions was
confirmed by Western blot analysis using antibody against
E-cadherin as a membrane marker and antibody anti–lactate de-
hydrogenase as a cytosolic marker (Fig. 2 C). The ratio of the
Flag-tagged NOD2 3020insC protein between membrane and
cytosolic fractions was significantly decreased compared with
that of the NOD2 wild-type protein, taken as one (Fig. 2 C).
GFP-tagged and Flag-tagged NOD2 colocalized in Caco-2 cells
(Fig. 2 D), indicating that the nature of the NH
 
2
 
-terminal tag did
not affect cellular localization. However, GFP-tagged NOD2
and Flag-tagged NOD2 3020insC mutant did not colocalize near
the plasma membrane, confirming the specific membrane asso-
ciation of the NOD2 wild type. This membrane association was
confirmed by using anti–E-cadherin antibody, a membrane
marker. As shown in Fig. 2 E, the GFP-NOD2 wild type colo-
calized with E-cadherin in Caco-2 cells.
 
The COOH-terminal protein domain 
directs the membrane targeting of NOD2
 
The difference between NOD2 wild type and NOD2 3020insC
mutant is the deletion of the final 33 COOH-terminal amino acid
residues, indicating that this region can be responsible for mem-
brane targeting. The domain of NOD2 that is responsible for
membrane targeting was more specifically identified by serial
deletion mutants (Fig. 3 A). Mutants 1 and 2 failed to localize to
Figure 1. Expression and cellular localization of endogenous NOD2.
(A) Western blot analysis using rabbit NOD2 antiserum HM2559 and
anti– -actin. 10  g of total protein from different intestinal epithelial cells
(IEC), COS7, and HEK293 cell lines were loaded onto 4–12% Tris-glycine
gel. (B) NF- B activation in HT29 and Caco-2 cells after stimulation with
1  g/ml MDP-LD or MDP-LL using NF- B luciferase reporter assay and nor-
malization with renilla after 18 h of transfection. Error bars represent SEM
of at least four separate experiments. *, P   0.05. (C) Confocal micros-
copy examination of endogenous NOD2 in HT29 and Caco-2 cells using
rabbit NOD2 antiserum HM2559 or preimmune serum and anti–rabbit
Texas red as a secondary antibody. Cytosolic and surface membrane
localization (arrows) of NOD2 in HT29 cells is shown. Bar, 20  m. 
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the cell membranes in Caco-2 cells (Fig. 3 B), indicating that the
terminal six amino acid residues of NOD2 are required for mem-
brane targeting. Mutants 3 and 4 were constructed by adding se-
lected COOH-terminal amino acids (last 6 and 17 amino acid
residues of NOD2) to the NOD2 3020insC mutant to determine
whether these amino acids were sufficient to confer NOD2 mem-
brane association. No membrane targeting in Caco-2 cells that
were transfected with these two mutant forms was observed. In-
stead, these NOD2 mutants were targeted to an intracellular vesi-
cle compartment (Fig. 3 B). Therefore, the last six amino acid
residues of NOD2 are necessary but not sufficient to confer
membrane targeting. Finally, the deletion of LERNDILE (mu-
tant 5) and VWLRGNTF (mutant 6), which are located in the
COOH-terminal domain of NOD2, also resulted in the loss of
membrane targeting in transfected Caco-2 cells (Fig. 3 B). The
identical distribution of all of these mutant forms of NOD2 was
observed when transfected into COS7 cells, including the con-
comitant loss of membrane targeting (unpublished data) com-
pared with wild-type NOD2, which indicates that the final 33
amino acids play a crucial role for NOD2 membrane recruitment.
Several substitution mutations were also introduced in
the COOH-terminal domain of NOD2 (Fig. 3 A). Mutant 7—
with substitution of amino acids GG for LL at the end of
NOD2—and mutant 11—with substitution WLR
 
1017
 
GGG—
lost their membrane targeting, whereas the other substitution
mutants still showed membrane association (Fig. 3 B). For mu-
tants that failed to colocalize with the plasma membrane, as
well as for the NOD2 3020insC mutant, some vesicular stain-
ing was observed. By using calnexin, an ER marker, we found
that some of these vesicles are within the ER compartment
(Fig. 3 C). These results indicate that the two last leucine resi-
dues and the WLR motif are required for membrane targeting.
 
NF-
 
 
 
B activation by MDP-LD is dependent 
on the membrane targeting of NOD2
 
NOD2 is known to activate the nuclear transcription factor
NF-
 
 
 
B after MDP-LD stimulation, and the NOD2 3020insC
mutant’s ability to activate NF-
 
 
 
B is impaired (Girardin et al.,
2003). The inability of the NOD2 mutant to respond to MDP-LD
and activate NF-
 
 
 
B in CD is paradoxical, considering that
Figure 2. Membrane association of expressed NOD2. (A) Amino acid sequences of the COOH-terminal domain of NOD2 and the NOD2 3020insC
mutant, which is associated with CD. (B) Confocal microscopy examination of Caco-2 cells that are transfected with Flag-NOD2, Flag-NOD2 3020insC
mutant, and empty vector (pCMVtag2C) shows the membrane association of NOD2 (arrows) but not of the NOD2 mutant. NOD2 and 3020insC mutant
were detected by using monoclonal anti-Flag antibody followed by fluorescein-conjugated anti–mouse IgG. (C) Western blot analysis using anti-Flag, anti–
E-cadherin, or anti–lactate dehydrogenase antibodies. Caco-2 cells were transfected with Flag-NOD2 (WT) or Flag-NOD2 3020insC (mutant). Cytosolic
(C) and membrane (M) fractions were separated as described in Materials and methods. Proteins were fractionated through 4–12% Tris-glycine SDS-
PAGE and were subjected to Western blot analysis by using anti-Flag antibody to detect NOD2 expression. The ratio in the membrane and cytosolic
fractions that were determined after the quantification of NOD2 3020insC mutant was compared with NOD2 wild type. The result is the mean of four
separate experiments. Error bar represents SEM. *, P   0.05. (D) Caco-2 cells were cotransfected with GFP-NOD2 and Flag-NOD2 or with GFP-NOD2
and Flag-NOD2 3020insC mutant and were detected using anti-Flag antibody for Flag-tagged constructs. Only the NOD2 wild type showed plasma
membrane association (arrows). (E) Caco-2 cells that were transfected with GFP-NOD2 were stained with anti–E-cadherin antibody, a membrane marker,
to confirm the plasma membrane association of the NOD2 wild type. Bars, 20  m. 
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NF-
 
 
 
B is responsible for the induction of a large number of in-
flammatory mediators (O’Neill, 2004). To investigate whether
the membrane targeting of NOD2 is required for MDP response,
we transfected HEK293 cells with NOD2 wild type and different
COOH-terminal mutants without tag. NOD2 expression was
confirmed by Western blot analysis using antiserum HM2563
against NOD2 (Fig. 4 A). As shown in Fig. 4 B, NOD2 wild type
induced a 47-fold increase in NF-
 
 
 
B activation, whereas mutants
1–7 and 11 induced less than a 3-fold increase in NF-
 
 
 
B. How-
ever, mutants 8–10 and 12, which are still membrane associated,
activated NF-
 
 
 
B. No NF-
 
 
 
B activation was observed after stim-
ulation with an MDP L-Ala, L-Glx (MDP-LL)–inactive form
(unpublished data). The release of IL-8 by HEK293 cells trans-
fected with NOD2 and selected mutants after MDP-LD stimula-
tion was determined by ELISA to confirm the NF-
 
 
 
B activation.
The amount of IL-8 found in the supernatant of HEK293 cells
that were transfected with NOD2 and stimulated with MDP-LD
(10.55 pg/ml) was significantly increased compared with un-
transfected cells (0.47 pg/ml). The amount of IL-8 released in the
supernatant of HEK293 cells that were transfected with the se-
lected NOD2 mutants correlated with NF-
 
 
 
B activation (Fig. 4
C). These results demonstrate that the membrane targeting of
NOD2 in intestinal epithelial cells is required for NF-
 
 
 
B activa-
tion upon the recognition of MDP. NOD2 binds to RIP2, a cyto-
plasmic protein, via a CARD–CARD interaction (Kobayashi et
al., 2002), suggesting that signaling of NOD2 at the membrane
implies either NOD2 redistribution to the cytoplasm after MDP-
LD stimulation or recruitment of RIP2 to the membrane.
 
Role of WLR
 
1017
 
, R
 
702
 
, and G
 
908
 
 in 
MDP-LD recognition
 
To determine which amino acid residues in the WLR motif are
required for MDP recognition, we constructed three additional
mutants (Fig. 5 A). NF-
 
 
 
B activation showed that both
W
 
1017
 
G (mutant 13) and L
 
1018
 
G (mutant 14) play vital roles in
MDP-LD recognition because NF-
 
 
 
B activation is signifi-
cantly decreased compared with wild-type NOD2. However,
Figure 3. NOD2 membrane association is COOH-terminal dependent. (A) Sequences of Flag-NOD2 COOH-terminal deletion and substitution mutants.
(B) Caco-2 cells were transfected with Flag-NOD2 mutant constructs. Mutants 1–12 were detected by confocal microscopy using monoclonal anti-Flag antibody
followed by fluorescein-conjugated anti–mouse IgG. Membrane association is still observed for some NOD2 mutants (arrows). (C) COS7 cells were transfected
with GFP-NOD2 3020insC and were stained with calnexin (ER marker). Some of the observed vesicles colocalized with calnexin (arrows). Bars, 20  m.
Figure 4. Ligand-induced NF- B activation and IL-8 release are dependent
on NOD2 membrane association. (A) Expression of NOD2 and mutants with-
out tag that were transfected into HEK293 cells was determined by Western
blot analysis using NOD2 antiserum HM2563. (B) HEK293 cells were trans-
fected with 1 ng NOD2 expression vector or mutants together with 1  g
MDP-LD. NF- B activity was determined by using an NF- B luciferase reporter
assay and was normalized with renilla after 18 h of transfection. Fold in-
crease of NF- B activation was determined by comparing untransfected and
nonstimulated HEK293 with MDP. (C) IL-8 released in the supernatant of
HEK293 cells that were transfected with mutants (M) of NOD2 and stimulated
18 h with 1  g MDP-LD was measured by ELISA. Error bars represent SEM of
at least four separate experiments. NT, nontransfected. *, P   0.05. 
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R
 
1019
 
G substitution (mutant 15) had no effect on NOD2 MDP-
LD recognition. These results were confirmed by determining
the amounts of IL-8 released in the supernatant of HEK293
cells that were transfected with these mutants (unpublished
data). Substitutions W
 
1017
 
G and L
 
1018
 
G led only to a twofold
decrease of NF-
 
 
 
B, whereas WLR
 
1017
 
GGG substitutions had
impaired NF-
 
 
 
B activation, indicating that both W and L
amino acid residues are important but not sufficient to com-
pletely abrogate NOD2 function. However, the two other
NOD2 mutants that are associated with CD—NOD2 R702W
and NOD2 G908R—still showed membrane association in
transfected COS7 cells, whereas these two mutants showed
decreased levels of NF-
 
 
 
B activation after MDP-LD stimula-
tion. This suggested that these two amino acids are required
for MDP-LD recognition but did not play any role in the
membrane targeting of NOD2 (Fig. 5 B).
In summary, the subcellular localization of NOD2 is im-
portant for ligand binding because cell membrane localization
in intestinal epithelial cells was required for NOD2 to recognize
MDP-LD after its transport across the cell membrane. However,
in contrast to Toll-like receptors that recognize bacterial compo-
nents outside the cell, NOD2 does not contain a transmembrane
domain and does not act as a membrane receptor. Furthermore,
the observed membrane association of NOD2 could be an inter-
action with the inner side of the plasma membrane but not with
cell surface expression. This study suggested that NOD2 mem-
brane association is necessary for NOD2 function as an innate
immune receptor, which is impaired for the most common
NOD2 mutant associated with CD.
 
Materials and methods
 
Cell culture and transfection
 
Caco-2, T84, HT29, HCT116, Colo205, SW480, LS174, COS7, and
HEK293 cells were obtained from the American Type Culture Collection
and were cultured as described previously (Hisamatsu et al., 2003). For
NF-
 
 
 
B assay or protein expression, cells were transfected using Lipo-
fectAMINE 2000 (Invitrogen), and for immunostaining experiments, cells
were transfected using TransIT Transfection Reagent Kit (Mirus Bio Corp.)
according to the manufacturer’s protocols.
 
Construction of expression plasmids
 
Flag-tagged (pCMVtag2c-NOD2) and GFP-tagged (pEGFPC1-NOD2)
NOD2 mammalian expression vectors were described previously (Hisa-
matsu et al., 2003). NOD2 mammalian expression vector without tag was
provided by M. Chamaillard (Institut National de la Santé et de la Recher-
che Medicale, Lille, France). All NOD2 mutants were generated by PCR
using the QuickChange Site-Directed Mutagenesis Kit (Stratagene) accord-
ing to the manufacturer’s protocols and were sequenced. Expression was
confirmed by Western blot analysis using mouse anti-Flag M2 mAb
(Sigma-Aldrich) or rabbit antiserum HM2559 or HM2563 against NOD2
(Hisamatsu et al., 2003).
 
Confocal microscopy
 
HT29, Caco-2, or COS7 cells were seeded on sterile permanox coverslips
and were transfected after 24 h with various NOD2 constructs. After 48 h,
cells were washed twice with ice-cold PBS, fixed 10 min with cold metha-
nol at 
 
 
 
20
 
 
 
C, washed three times with ice-cold PBS, and blocked 30
min with 5% donkey serum in PBS. Cells were stained using rabbit
NOD2 antiserum HM2559 and Texas red–conjugated anti–rabbit IgG
(Vector Laboratories) secondary antibodies for endogenous NOD2 or us-
ing mouse anti-Flag M2 mAb (Sigma-Aldrich) and FITC-conjugated anti–
mouse IgG secondary antibodies. The coverslips were mounted in
Vectashield (Vector Laboratories) and examined at RT with a confocal mi-
croscope (model Radiance 2000; Bio-Rad Laboratories) using multitrack-
ing (line switching) for two-color imaging (40
 
 
 
). Image acquisition was
performed with LaserSharpScanning software (Bio-Rad Laboratories). For
vesicular staining, anticalnexin rabbit pAb (StressGen Biotechnologies)
Figure 5. Ligand-induced NF- B activation are dependent on a three–amino acid motif that is required for membrane association. (A, 1) Amino acid
sequences of Flag-NOD2 COOH-terminal substitution mutants. (2) Expression of these mutants was determined by Western blot analysis using NOD2
antiserum HM2563. (3) Fold increase of NF- B activation was determined as described in Fig. 4. (B, 1) GFP-NOD2 wild type and the three main
NOD2 mutations that are associated with CD (GFP-NOD2 3020insC, GFP-NOD2 R702W, and GFP-NOD2 G908R) were transfected in COS7 cells.
Only NOD2 3020insC failed to colocalize with the plasma membrane, whereas the two other NOD2 mutant forms still showed membrane association
(arrows). Bar, 20  m. (2) Expression of NOD2 mutants and NF- B activation were determined and compared with untransfected and nonstimulated
HEK293 with MDP-LD, as described in Fig. 4. Error bars represent SEM of at least four separate experiments. *, P   0.05. 
JCB • VOLUME 170 • NUMBER 1 • 2005 26
 
was used in COS7 cells followed by Texas red–conjugated anti–rabbit
IgG secondary antibodies.
 
NF-
 
 
 
B activation assay and detection of cytokine IL-8 in the supernatant of 
transfected cells
 
HEK293 cells were transfected overnight with 1 ng NOD2, 10 ng pIV lu-
ciferase reporter plasmid, and 1 ng of renilla plasmid together with 1 
 
 
 
g
MDP-LD or MDP-LL (Sigma-Aldrich). After 18 h, luciferase activity was mea-
sured by using the Dual-Luciferase Reporter Assay System (Promega) accord-
ing to the manufacturer’s instructions and was normalized to renilla activity.
The amount of human cytokine IL-8 released in the supernatant of
HEK293 cells that were transfected with 1 ng NOD2 or different NOD2
mutants was determined by ELISA (BD Biosciences). The optical density
was determined at a wavelength of 450 nm, and cytokine concentrations
in picograms per milliliter were assessed according to the manufacturer’s
instructions.
 
Protein extraction and immunoblotting experiments
 
Cells were seeded on 6-well plates and were transfected 24 h later with
1 
 
 
 
g DNA. Medium was removed, and 300 
 
 
 
l of lysis buffer (1% Triton
X-100, 0.1 M NaCl, 10 mM Hepes, pH 5.6, 2 mM EDTA, 4 mM
Na
 
3
 
VO
 
4
 
, and 40 mM NaF) supplemented with protease inhibitor cocktail
(Complete Mini; Roche Diagnostics) was added. Lysates were harvested
and passed through a 21-gauge needle 10 times. The cytosolic fraction
was obtained by centrifugation at 10,000 
 
g
 
 for 30 min at 4
 
 
 
C. The pellet
was resuspended in 200 
 
 
 
l of lysis buffer containing 1% SDS and was
sonicated twice for 20 s. After 5 min of centrifugation at 10,000 
 
g
 
, the re-
sulting supernatant was collected. The protein concentration was deter-
mined by using the DC Protein Assay Kit (Bio-Rad Laboratories).
10 
 
 
 
g of proteins from all intestinal epithelial cells were separated
on 4–12% Tris-glycine gels (Invitrogen), blotted onto polyvinylidene difluo-
ride membranes, and stained for NOD2 using rabbit NOD2 antiserum
HM2559. Proteins from Caco-2 cells that were transfected with Flag-
tagged NOD2 and all mutants were separated on 4–12% Tris-glycine
gel (Invitrogen), blotted onto polyvinylidene difluoride membranes, and
stained using anti-Flag M2 mAb (Sigma-Aldrich), anti–E-cadherin mAb (BD
Biosciences), anti–lactate dehydrogenase (Abcam), or anti–
 
 
 
-actin (C-11;
Santa Cruz Biotechnology, Inc.).
 
Statistical analysis
 
For the analysis of significant differences in NF-
 
 
 
B activation or IL-8 re-
lease, a t test was used. All experiments were repeated at least four times.
P   0.05 was considered to be statistically significant.
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